FDA Advisory Committee Split on Renal Denervation Systems; The FDA Circulatory System Devices Panel has voted in favor of the benefit-risk profile of Recor Medical's RDN system in a 10-2 vote but declined to endorse Medtronic's system in a 6-7 vote.

Media coverage

• Title	FDA Advisory Committee Split on Renal Denervation Systems; The FDA Circulatory System Devices Panel has voted in favor of the benefit-risk profile of Recor Medical's RDN system in a 10-2 vote but declined to endorse Medtronic's system in a 6-7 vote.
  Media name/outlet	Consultant Live
  Country/Territory	United States
  Date	24/08/23
  URL	metabase.moreover.com/noarticleurl?type=psh&lni=6919-PJW1-F0CR-J482-00000-00
  Persons	George Dangas,

• Title	FDA Advisory Committee Split on Renal Denervation Systems
  Media name/outlet	HCP Live
  Country/Territory	United States
  Date	24/08/23
  URL	metabase.moreover.com/noarticleurl?type=psh&lni=6919-Y8S1-F0CR-J0TM-00000-00
  Persons	George Dangas,